Furthermore, as reported recently by others [17], Rapa and IL-2 displayed synergism in protecting against GVHD-induced weight loss (Figure 6A), although we could not observe a significant synergistic effect in clinical score or GVHD mortality (Figure 6B-C). The gene discussed is TRERF1; the disease is graft versus host disease.